Memorial Sloan Kettering Cancer Center: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials
The registry lists 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 2 are open to participants now and 1 have results posted.
Phase 1 8Phase 2 3Phase 3 2No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1RecruitingNCT06698003Phase 2
- A Registry for People With T-cell LymphomaRecruitingNCT05978141
- Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous TreatmentCompletedNCT00416351Phase 1/2Results posted
- Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerCompletedNCT00045006Phase 1
- Pyroxamide in Treating Patients With Advanced CancerCompletedNCT00042900Phase 1
- ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00016172Phase 1
- Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer TreatmentCompletedNCT00008359Phase 3
- St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for CancerCompletedNCT00005805Phase 3
- Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00005634Phase 1
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's LymphomaCompletedNCT00005040Phase 2
- Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or LymphomasCompletedNCT00004057Phase 1
- Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00003956Phase 1
- Arsenic Trioxide in Treating Patients With Advanced Hematologic CancerCompletedNCT00003395Phase 1